Next Biomedical Co.,Ltd. (KOSDAQ:389650)

South Korea flag South Korea · Delayed Price · Currency is KRW
63,500
+1,600 (2.58%)
At close: Aug 28, 2025
2.58%
Market Cap516.06B
Revenue (ttm)12.16B
Net Income (ttm)2.57B
Shares Out8.13M
EPS (ttm)-272.78
PE Ratio200.46
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume150,755
Average Volume101,063
Open62,900
Previous Close61,900
Day's Range61,700 - 65,200
52-Week Range27,200 - 63,900
Betan/a
RSI69.45
Earnings Daten/a

About Next Biomedical

Next Biomedical Co.,Ltd. engages in the research and development, production, and development of therapeutics, drug delivery system and drug-medical device products in South Korea. It offers hemostatic material for endoscope; and microspheres for vascular embolization. The company was founded in 2014 and is based in Incheon, South Korea. [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2014
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 389650
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.